nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—PTK2—hypertension	0.156	0.403	CbGaD
Crizotinib—RPS6KB1—hypertension	0.127	0.329	CbGaD
Crizotinib—SRC—hypertension	0.0663	0.171	CbGaD
Crizotinib—CYP3A5—hypertension	0.0376	0.0969	CbGaD
Crizotinib—CYP3A5—Reserpine—hypertension	0.00721	0.0346	CbGbCtD
Crizotinib—CYP3A5—Nisoldipine—hypertension	0.00635	0.0305	CbGbCtD
Crizotinib—ABCB1—Nadolol—hypertension	0.0062	0.0297	CbGbCtD
Crizotinib—CYP3A5—Diltiazem—hypertension	0.00613	0.0294	CbGbCtD
Crizotinib—CYP3A5—Eplerenone—hypertension	0.00613	0.0294	CbGbCtD
Crizotinib—ABCB1—Acebutolol—hypertension	0.00567	0.0272	CbGbCtD
Crizotinib—ABCB1—Candesartan—hypertension	0.00527	0.0253	CbGbCtD
Crizotinib—ABCB1—Metoprolol—hypertension	0.00527	0.0253	CbGbCtD
Crizotinib—ABCB1—Terazosin—hypertension	0.00495	0.0238	CbGbCtD
Crizotinib—CYP3A5—Amlodipine—hypertension	0.0049	0.0235	CbGbCtD
Crizotinib—CYP3A4—Guanethidine—hypertension	0.0049	0.0235	CbGbCtD
Crizotinib—CYP3A5—Felodipine—hypertension	0.00473	0.0227	CbGbCtD
Crizotinib—ABCB1—Reserpine—hypertension	0.0047	0.0225	CbGbCtD
Crizotinib—CYP3A5—Nifedipine—hypertension	0.00457	0.0219	CbGbCtD
Crizotinib—CYP3A5—Nicardipine—hypertension	0.0045	0.0216	CbGbCtD
Crizotinib—ABCB1—Perindopril—hypertension	0.00429	0.0206	CbGbCtD
Crizotinib—CYP3A5—Propranolol—hypertension	0.00414	0.0199	CbGbCtD
Crizotinib—ABCB1—Doxazosin—hypertension	0.00413	0.0198	CbGbCtD
Crizotinib—ABCB1—Nisoldipine—hypertension	0.00413	0.0198	CbGbCtD
Crizotinib—ABCB1—Diltiazem—hypertension	0.00399	0.0192	CbGbCtD
Crizotinib—CYP3A5—Clonidine—hypertension	0.00395	0.019	CbGbCtD
Crizotinib—ABCB1—Telmisartan—hypertension	0.00375	0.018	CbGbCtD
Crizotinib—CYP3A4—Hydralazine—hypertension	0.00371	0.0178	CbGbCtD
Crizotinib—ABCB1—Bepridil—hypertension	0.00356	0.0171	CbGbCtD
Crizotinib—ABCB1—Lisinopril—hypertension	0.00356	0.0171	CbGbCtD
Crizotinib—ABCB1—Enalapril—hypertension	0.00356	0.0171	CbGbCtD
Crizotinib—CYP3A5—Atorvastatin—hypertension	0.00352	0.0169	CbGbCtD
Crizotinib—ABCB1—Prazosin—hypertension	0.00339	0.0163	CbGbCtD
Crizotinib—CYP3A5—Losartan—hypertension	0.00322	0.0155	CbGbCtD
Crizotinib—ABCB1—Amlodipine—hypertension	0.00319	0.0153	CbGbCtD
Crizotinib—CYP3A4—Guanfacine—hypertension	0.00316	0.0151	CbGbCtD
Crizotinib—ABCB1—Spironolactone—hypertension	0.00313	0.015	CbGbCtD
Crizotinib—ABCB1—Felodipine—hypertension	0.00308	0.0148	CbGbCtD
Crizotinib—ABCB1—Timolol—hypertension	0.00303	0.0145	CbGbCtD
Crizotinib—ABCB1—Nifedipine—hypertension	0.00298	0.0143	CbGbCtD
Crizotinib—ABCB1—Carvedilol—hypertension	0.00293	0.0141	CbGbCtD
Crizotinib—ABCB1—Nicardipine—hypertension	0.00293	0.0141	CbGbCtD
Crizotinib—CYP3A5—Verapamil—hypertension	0.00284	0.0136	CbGbCtD
Crizotinib—CYP3A4—Isradipine—hypertension	0.00281	0.0135	CbGbCtD
Crizotinib—ABCB1—Propranolol—hypertension	0.0027	0.0129	CbGbCtD
Crizotinib—ABCB1—Captopril—hypertension	0.00266	0.0128	CbGbCtD
Crizotinib—ABCB1—Clonidine—hypertension	0.00257	0.0123	CbGbCtD
Crizotinib—CYP3A4—Nisoldipine—hypertension	0.00248	0.0119	CbGbCtD
Crizotinib—CYP3A4—Indapamide—hypertension	0.00248	0.0119	CbGbCtD
Crizotinib—CYP3A4—Diltiazem—hypertension	0.00239	0.0115	CbGbCtD
Crizotinib—CYP3A4—Eplerenone—hypertension	0.00239	0.0115	CbGbCtD
Crizotinib—ABCB1—Atorvastatin—hypertension	0.00229	0.011	CbGbCtD
Crizotinib—CYP3A4—Enalapril—hypertension	0.00213	0.0102	CbGbCtD
Crizotinib—ABCB1—Losartan—hypertension	0.0021	0.0101	CbGbCtD
Crizotinib—CYP3A4—Irbesartan—hypertension	0.00195	0.00935	CbGbCtD
Crizotinib—CYP3A4—Amlodipine—hypertension	0.00191	0.00917	CbGbCtD
Crizotinib—ABCB1—Verapamil—hypertension	0.00185	0.00888	CbGbCtD
Crizotinib—CYP3A4—Felodipine—hypertension	0.00184	0.00885	CbGbCtD
Crizotinib—CYP3A4—Nifedipine—hypertension	0.00178	0.00856	CbGbCtD
Crizotinib—CYP3A4—Nicardipine—hypertension	0.00176	0.00842	CbGbCtD
Crizotinib—CYP3A4—Carvedilol—hypertension	0.00176	0.00842	CbGbCtD
Crizotinib—CYP3A4—Propranolol—hypertension	0.00162	0.00775	CbGbCtD
Crizotinib—CYP3A4—Clonidine—hypertension	0.00154	0.00739	CbGbCtD
Crizotinib—CYP3A4—Atorvastatin—hypertension	0.00137	0.00659	CbGbCtD
Crizotinib—CYP3A4—Losartan—hypertension	0.00126	0.00603	CbGbCtD
Crizotinib—CYP3A4—Verapamil—hypertension	0.00111	0.00532	CbGbCtD
Crizotinib—TESK1—Enalapril—Captopril—hypertension	0.000318	0.117	CbGdCrCtD
Crizotinib—TESK1—Enalapril—Fosinopril—hypertension	0.000227	0.0835	CbGdCrCtD
Crizotinib—TESK1—Enalapril—Moexipril—hypertension	0.000197	0.0724	CbGdCrCtD
Crizotinib—CASK—Pitavastatin—Atorvastatin—hypertension	0.000181	0.0667	CbGdCrCtD
Crizotinib—TESK1—Enalapril—Perindopril—hypertension	0.000172	0.0633	CbGdCrCtD
Crizotinib—IGF1R—Pitavastatin—Atorvastatin—hypertension	0.00017	0.0627	CbGdCrCtD
Crizotinib—TESK1—Enalapril—Quinapril—hypertension	0.000163	0.06	CbGdCrCtD
Crizotinib—TESK1—Enalapril—Benazepril—hypertension	0.000159	0.0586	CbGdCrCtD
Crizotinib—PTK2B—Pindolol—Nadolol—hypertension	0.000141	0.0517	CbGdCrCtD
Crizotinib—LYN—endocrine gland—hypertension	0.000137	0.00149	CbGeAlD
Crizotinib—EPHB4—smooth muscle tissue—hypertension	0.000137	0.00149	CbGeAlD
Crizotinib—FGR—cardiovascular system—hypertension	0.000137	0.00149	CbGeAlD
Crizotinib—MAP3K3—adrenal cortex—hypertension	0.000136	0.00149	CbGeAlD
Crizotinib—TEK—adrenal cortex—hypertension	0.000136	0.00149	CbGeAlD
Crizotinib—LIMK2—adrenal gland—hypertension	0.000136	0.00148	CbGeAlD
Crizotinib—PTK2—cortex of kidney—hypertension	0.000136	0.00148	CbGeAlD
Crizotinib—TBK1—cortex of kidney—hypertension	0.000136	0.00148	CbGeAlD
Crizotinib—AXL—cardiovascular system—hypertension	0.000136	0.00148	CbGeAlD
Crizotinib—TNK1—endocrine gland—hypertension	0.000136	0.00148	CbGeAlD
Crizotinib—JAK2—smooth muscle tissue—hypertension	0.000136	0.00148	CbGeAlD
Crizotinib—NUAK2—adrenal gland—hypertension	0.000136	0.00148	CbGeAlD
Crizotinib—TYK2—cortex of kidney—hypertension	0.000135	0.00147	CbGeAlD
Crizotinib—EPHA2—heart—hypertension	0.000135	0.00147	CbGeAlD
Crizotinib—SLK—decidua—hypertension	0.000135	0.00147	CbGeAlD
Crizotinib—EPHA4—cardiac atrium—hypertension	0.000135	0.00147	CbGeAlD
Crizotinib—MAP3K12—adrenal gland—hypertension	0.000135	0.00147	CbGeAlD
Crizotinib—FLT3—adrenal gland—hypertension	0.000135	0.00147	CbGeAlD
Crizotinib—ACVR1—adrenal gland—hypertension	0.000135	0.00147	CbGeAlD
Crizotinib—BMPR1B—endocrine gland—hypertension	0.000135	0.00147	CbGeAlD
Crizotinib—RPS6KB1—kidney—hypertension	0.000135	0.00146	CbGeAlD
Crizotinib—TESK1—Enalapril—Trandolapril—hypertension	0.000134	0.0494	CbGdCrCtD
Crizotinib—EPHB4—decidua—hypertension	0.000134	0.00146	CbGeAlD
Crizotinib—JAK3—central nervous system—hypertension	0.000134	0.00145	CbGeAlD
Crizotinib—EPHA6—central nervous system—hypertension	0.000134	0.00145	CbGeAlD
Crizotinib—IRAK1—cortex of kidney—hypertension	0.000134	0.00145	CbGeAlD
Crizotinib—JAK2—decidua—hypertension	0.000133	0.00145	CbGeAlD
Crizotinib—DCLK1—central nervous system—hypertension	0.000133	0.00144	CbGeAlD
Crizotinib—IGF1R—endocrine gland—hypertension	0.000132	0.00144	CbGeAlD
Crizotinib—TNK2—endocrine gland—hypertension	0.000132	0.00144	CbGeAlD
Crizotinib—STK35—adrenal gland—hypertension	0.000132	0.00144	CbGeAlD
Crizotinib—MAP3K3—heart—hypertension	0.000132	0.00144	CbGeAlD
Crizotinib—TEK—heart—hypertension	0.000132	0.00144	CbGeAlD
Crizotinib—MAP4K5—heart—hypertension	0.000132	0.00144	CbGeAlD
Crizotinib—RIPK2—medulla oblongata—hypertension	0.000132	0.00143	CbGeAlD
Crizotinib—EPHA2—decidua—hypertension	0.000132	0.00143	CbGeAlD
Crizotinib—STK4—central nervous system—hypertension	0.000131	0.00143	CbGeAlD
Crizotinib—RPS6KB1—cortex of kidney—hypertension	0.000131	0.00143	CbGeAlD
Crizotinib—TEK—smooth muscle tissue—hypertension	0.000131	0.00143	CbGeAlD
Crizotinib—MAP4K5—smooth muscle tissue—hypertension	0.000131	0.00143	CbGeAlD
Crizotinib—MAP4K2—endocrine gland—hypertension	0.00013	0.00142	CbGeAlD
Crizotinib—EPHB4—cardiovascular system—hypertension	0.00013	0.00142	CbGeAlD
Crizotinib—AXL—cortex of kidney—hypertension	0.00013	0.00141	CbGeAlD
Crizotinib—TBK1—cardiac atrium—hypertension	0.00013	0.00141	CbGeAlD
Crizotinib—JAK2—cardiovascular system—hypertension	0.000129	0.00141	CbGeAlD
Crizotinib—ABL2—adrenal gland—hypertension	0.000129	0.0014	CbGeAlD
Crizotinib—TYK2—cardiac atrium—hypertension	0.000129	0.0014	CbGeAlD
Crizotinib—MAP3K3—decidua—hypertension	0.000128	0.0014	CbGeAlD
Crizotinib—MAP4K5—decidua—hypertension	0.000128	0.0014	CbGeAlD
Crizotinib—TEK—decidua—hypertension	0.000128	0.0014	CbGeAlD
Crizotinib—YES1—nephron tubule—hypertension	0.000128	0.00139	CbGeAlD
Crizotinib—EPHA2—cardiovascular system—hypertension	0.000128	0.00139	CbGeAlD
Crizotinib—EPHB4—kidney—hypertension	0.000127	0.00139	CbGeAlD
Crizotinib—EPHA4—medulla oblongata—hypertension	0.000127	0.00138	CbGeAlD
Crizotinib—BMP2K—adrenal gland—hypertension	0.000127	0.00138	CbGeAlD
Crizotinib—ABL1—cardiac ventricle—hypertension	0.000127	0.00138	CbGeAlD
Crizotinib—JAK2—kidney—hypertension	0.000126	0.00138	CbGeAlD
Crizotinib—TAOK3—nephron tubule—hypertension	0.000126	0.00138	CbGeAlD
Crizotinib—EPHB6—heart—hypertension	0.000126	0.00137	CbGeAlD
Crizotinib—YES1—adrenal cortex—hypertension	0.000126	0.00137	CbGeAlD
Crizotinib—AURKA—endocrine gland—hypertension	0.000125	0.00136	CbGeAlD
Crizotinib—SLK—cortex of kidney—hypertension	0.000125	0.00136	CbGeAlD
Crizotinib—RPS6KB1—cardiac atrium—hypertension	0.000125	0.00136	CbGeAlD
Crizotinib—MAP3K3—cardiovascular system—hypertension	0.000125	0.00136	CbGeAlD
Crizotinib—TEK—cardiovascular system—hypertension	0.000125	0.00136	CbGeAlD
Crizotinib—TAOK3—adrenal cortex—hypertension	0.000124	0.00135	CbGeAlD
Crizotinib—TESK1—endocrine gland—hypertension	0.000124	0.00135	CbGeAlD
Crizotinib—EPHB4—cortex of kidney—hypertension	0.000124	0.00135	CbGeAlD
Crizotinib—EPHA5—central nervous system—hypertension	0.000124	0.00135	CbGeAlD
Crizotinib—ALK—central nervous system—hypertension	0.000124	0.00135	CbGeAlD
Crizotinib—TYRO3—central nervous system—hypertension	0.000124	0.00135	CbGeAlD
Crizotinib—FER—central nervous system—hypertension	0.000124	0.00135	CbGeAlD
Crizotinib—PTK2B—Pindolol—Acebutolol—hypertension	0.000124	0.0456	CbGdCrCtD
Crizotinib—AXL—cardiac atrium—hypertension	0.000123	0.00134	CbGeAlD
Crizotinib—LYN—central nervous system—hypertension	0.000123	0.00134	CbGeAlD
Crizotinib—JAK2—cortex of kidney—hypertension	0.000123	0.00134	CbGeAlD
Crizotinib—PTK2B—adrenal gland—hypertension	0.000123	0.00134	CbGeAlD
Crizotinib—EPHB6—decidua—hypertension	0.000123	0.00134	CbGeAlD
Crizotinib—TBK1—medulla oblongata—hypertension	0.000122	0.00133	CbGeAlD
Crizotinib—YES1—heart—hypertension	0.000122	0.00133	CbGeAlD
Crizotinib—TEK—kidney—hypertension	0.000122	0.00133	CbGeAlD
Crizotinib—RIPK2—adrenal gland—hypertension	0.000122	0.00133	CbGeAlD
Crizotinib—MAP3K19—central nervous system—hypertension	0.000121	0.00132	CbGeAlD
Crizotinib—BMPR1B—central nervous system—hypertension	0.000121	0.00132	CbGeAlD
Crizotinib—TYK2—medulla oblongata—hypertension	0.000121	0.00132	CbGeAlD
Crizotinib—YES1—smooth muscle tissue—hypertension	0.000121	0.00132	CbGeAlD
Crizotinib—MERTK—endocrine gland—hypertension	0.000121	0.00132	CbGeAlD
Crizotinib—STK10—heart—hypertension	0.000121	0.00131	CbGeAlD
Crizotinib—TAOK3—heart—hypertension	0.00012	0.00131	CbGeAlD
Crizotinib—ABL1—myocardium—hypertension	0.000119	0.0013	CbGeAlD
Crizotinib—TNK2—central nervous system—hypertension	0.000119	0.0013	CbGeAlD
Crizotinib—IGF1R—central nervous system—hypertension	0.000119	0.0013	CbGeAlD
Crizotinib—SLK—cardiac atrium—hypertension	0.000119	0.00129	CbGeAlD
Crizotinib—TEK—cortex of kidney—hypertension	0.000119	0.00129	CbGeAlD
Crizotinib—MAP4K5—cortex of kidney—hypertension	0.000119	0.00129	CbGeAlD
Crizotinib—MAP3K3—cortex of kidney—hypertension	0.000119	0.00129	CbGeAlD
Crizotinib—YES1—decidua—hypertension	0.000119	0.00129	CbGeAlD
Crizotinib—LIMK2—endocrine gland—hypertension	0.000118	0.00129	CbGeAlD
Crizotinib—EPHB4—cardiac atrium—hypertension	0.000118	0.00128	CbGeAlD
Crizotinib—EPHA4—adrenal gland—hypertension	0.000118	0.00128	CbGeAlD
Crizotinib—RPS6KB1—medulla oblongata—hypertension	0.000118	0.00128	CbGeAlD
Crizotinib—STK10—decidua—hypertension	0.000118	0.00128	CbGeAlD
Crizotinib—SRC—heart—hypertension	0.000117	0.00128	CbGeAlD
Crizotinib—JAK2—cardiac atrium—hypertension	0.000117	0.00127	CbGeAlD
Crizotinib—TAOK3—decidua—hypertension	0.000117	0.00127	CbGeAlD
Crizotinib—MAP3K12—endocrine gland—hypertension	0.000117	0.00127	CbGeAlD
Crizotinib—ACVR1—endocrine gland—hypertension	0.000117	0.00127	CbGeAlD
Crizotinib—FLT3—endocrine gland—hypertension	0.000117	0.00127	CbGeAlD
Crizotinib—AXL—medulla oblongata—hypertension	0.000116	0.00127	CbGeAlD
Crizotinib—SRC—smooth muscle tissue—hypertension	0.000116	0.00127	CbGeAlD
Crizotinib—TIE1—central nervous system—hypertension	0.000116	0.00126	CbGeAlD
Crizotinib—EPHA2—cardiac atrium—hypertension	0.000116	0.00126	CbGeAlD
Crizotinib—MAP3K2—adrenal gland—hypertension	0.000116	0.00126	CbGeAlD
Crizotinib—STK35—endocrine gland—hypertension	0.000115	0.00125	CbGeAlD
Crizotinib—SRC—decidua—hypertension	0.000114	0.00124	CbGeAlD
Crizotinib—STK10—cardiovascular system—hypertension	0.000114	0.00124	CbGeAlD
Crizotinib—TAOK3—cardiovascular system—hypertension	0.000114	0.00124	CbGeAlD
Crizotinib—EPHB6—cortex of kidney—hypertension	0.000113	0.00123	CbGeAlD
Crizotinib—TBK1—adrenal gland—hypertension	0.000113	0.00123	CbGeAlD
Crizotinib—PTK2—adrenal gland—hypertension	0.000113	0.00123	CbGeAlD
Crizotinib—AURKA—central nervous system—hypertension	0.000113	0.00123	CbGeAlD
Crizotinib—TEK—cardiac atrium—hypertension	0.000113	0.00123	CbGeAlD
Crizotinib—MAP3K3—cardiac atrium—hypertension	0.000113	0.00123	CbGeAlD
Crizotinib—MAP4K5—cardiac atrium—hypertension	0.000113	0.00123	CbGeAlD
Crizotinib—YES1—kidney—hypertension	0.000113	0.00122	CbGeAlD
Crizotinib—TYK2—adrenal gland—hypertension	0.000112	0.00122	CbGeAlD
Crizotinib—PTK2B—Pindolol—Metoprolol—hypertension	0.000112	0.0414	CbGdCrCtD
Crizotinib—SLK—medulla oblongata—hypertension	0.000112	0.00122	CbGeAlD
Crizotinib—TESK1—central nervous system—hypertension	0.000112	0.00122	CbGeAlD
Crizotinib—STK10—kidney—hypertension	0.000112	0.00121	CbGeAlD
Crizotinib—EPHB4—medulla oblongata—hypertension	0.000111	0.00121	CbGeAlD
Crizotinib—TAOK3—kidney—hypertension	0.000111	0.00121	CbGeAlD
Crizotinib—IRAK1—adrenal gland—hypertension	0.000111	0.00121	CbGeAlD
Crizotinib—SRC—cardiovascular system—hypertension	0.000111	0.0012	CbGeAlD
Crizotinib—JAK2—medulla oblongata—hypertension	0.00011	0.0012	CbGeAlD
Crizotinib—BMP2K—endocrine gland—hypertension	0.00011	0.0012	CbGeAlD
Crizotinib—YES1—cortex of kidney—hypertension	0.00011	0.00119	CbGeAlD
Crizotinib—MERTK—central nervous system—hypertension	0.000109	0.00119	CbGeAlD
Crizotinib—CSF1R—adrenal cortex—hypertension	0.000109	0.00118	CbGeAlD
Crizotinib—RPS6KB1—adrenal gland—hypertension	0.000109	0.00118	CbGeAlD
Crizotinib—SRC—kidney—hypertension	0.000108	0.00118	CbGeAlD
Crizotinib—TAOK3—cortex of kidney—hypertension	0.000108	0.00118	CbGeAlD
Crizotinib—LCK—adrenal gland—hypertension	0.000108	0.00118	CbGeAlD
Crizotinib—FGR—adrenal gland—hypertension	0.000108	0.00118	CbGeAlD
Crizotinib—EPHB6—cardiac atrium—hypertension	0.000108	0.00117	CbGeAlD
Crizotinib—AXL—adrenal gland—hypertension	0.000108	0.00117	CbGeAlD
Crizotinib—LIMK2—central nervous system—hypertension	0.000107	0.00116	CbGeAlD
Crizotinib—PTK2B—endocrine gland—hypertension	0.000107	0.00116	CbGeAlD
Crizotinib—PTK2B—Pindolol—Esmolol—hypertension	0.000107	0.0392	CbGdCrCtD
Crizotinib—MAP4K5—medulla oblongata—hypertension	0.000106	0.00116	CbGeAlD
Crizotinib—MAP3K3—medulla oblongata—hypertension	0.000106	0.00116	CbGeAlD
Crizotinib—TEK—medulla oblongata—hypertension	0.000106	0.00116	CbGeAlD
Crizotinib—RIPK2—endocrine gland—hypertension	0.000106	0.00115	CbGeAlD
Crizotinib—MAP3K12—central nervous system—hypertension	0.000105	0.00115	CbGeAlD
Crizotinib—ACVR1—central nervous system—hypertension	0.000105	0.00115	CbGeAlD
Crizotinib—CSF1R—heart—hypertension	0.000105	0.00115	CbGeAlD
Crizotinib—TESK1—Enalapril—Lisinopril—hypertension	0.000105	0.0387	CbGdCrCtD
Crizotinib—CSF1R—smooth muscle tissue—hypertension	0.000104	0.00114	CbGeAlD
Crizotinib—YES1—cardiac atrium—hypertension	0.000104	0.00113	CbGeAlD
Crizotinib—SLK—adrenal gland—hypertension	0.000104	0.00113	CbGeAlD
Crizotinib—STK35—central nervous system—hypertension	0.000103	0.00112	CbGeAlD
Crizotinib—EPHB4—adrenal gland—hypertension	0.000103	0.00112	CbGeAlD
Crizotinib—TAOK3—cardiac atrium—hypertension	0.000103	0.00112	CbGeAlD
Crizotinib—CSF1R—decidua—hypertension	0.000102	0.00111	CbGeAlD
Crizotinib—JAK2—adrenal gland—hypertension	0.000102	0.00111	CbGeAlD
Crizotinib—EPHA4—endocrine gland—hypertension	0.000102	0.00111	CbGeAlD
Crizotinib—EPHB6—medulla oblongata—hypertension	0.000102	0.00111	CbGeAlD
Crizotinib—TESK1—Enalapril—Ramipril—hypertension	0.000102	0.0374	CbGdCrCtD
Crizotinib—EPHA2—adrenal gland—hypertension	0.000101	0.0011	CbGeAlD
Crizotinib—SRC—cardiac atrium—hypertension	0.0001	0.00109	CbGeAlD
Crizotinib—MAP3K2—endocrine gland—hypertension	0.0001	0.00109	CbGeAlD
Crizotinib—BMP2K—central nervous system—hypertension	9.94e-05	0.00108	CbGeAlD
Crizotinib—CSF1R—cardiovascular system—hypertension	9.94e-05	0.00108	CbGeAlD
Crizotinib—MAP3K3—adrenal gland—hypertension	9.85e-05	0.00107	CbGeAlD
Crizotinib—MAP4K5—adrenal gland—hypertension	9.85e-05	0.00107	CbGeAlD
Crizotinib—TEK—adrenal gland—hypertension	9.85e-05	0.00107	CbGeAlD
Crizotinib—YES1—medulla oblongata—hypertension	9.83e-05	0.00107	CbGeAlD
Crizotinib—TBK1—endocrine gland—hypertension	9.81e-05	0.00107	CbGeAlD
Crizotinib—PTK2—endocrine gland—hypertension	9.81e-05	0.00107	CbGeAlD
Crizotinib—TYK2—endocrine gland—hypertension	9.74e-05	0.00106	CbGeAlD
Crizotinib—TAOK3—medulla oblongata—hypertension	9.7e-05	0.00106	CbGeAlD
Crizotinib—ABL1—brainstem—hypertension	9.62e-05	0.00105	CbGeAlD
Crizotinib—PTK2B—central nervous system—hypertension	9.6e-05	0.00104	CbGeAlD
Crizotinib—RPS6KB1—endocrine gland—hypertension	9.44e-05	0.00103	CbGeAlD
Crizotinib—EPHB6—adrenal gland—hypertension	9.42e-05	0.00102	CbGeAlD
Crizotinib—FGR—endocrine gland—hypertension	9.38e-05	0.00102	CbGeAlD
Crizotinib—PTK2B—Pindolol—Betaxolol—hypertension	9.38e-05	0.0345	CbGdCrCtD
Crizotinib—AXL—endocrine gland—hypertension	9.34e-05	0.00102	CbGeAlD
Crizotinib—EPHA4—central nervous system—hypertension	9.2e-05	0.001	CbGeAlD
Crizotinib—YES1—adrenal gland—hypertension	9.1e-05	0.00099	CbGeAlD
Crizotinib—MAP3K2—central nervous system—hypertension	9.03e-05	0.000982	CbGeAlD
Crizotinib—STK10—adrenal gland—hypertension	9.02e-05	0.000981	CbGeAlD
Crizotinib—CSF1R—cardiac atrium—hypertension	9.01e-05	0.00098	CbGeAlD
Crizotinib—TAOK3—adrenal gland—hypertension	8.98e-05	0.000977	CbGeAlD
Crizotinib—EPHB4—endocrine gland—hypertension	8.93e-05	0.000971	CbGeAlD
Crizotinib—JAK2—endocrine gland—hypertension	8.86e-05	0.000965	CbGeAlD
Crizotinib—PTK2—central nervous system—hypertension	8.84e-05	0.000962	CbGeAlD
Crizotinib—TBK1—central nervous system—hypertension	8.84e-05	0.000962	CbGeAlD
Crizotinib—TYK2—central nervous system—hypertension	8.78e-05	0.000955	CbGeAlD
Crizotinib—EPHA2—endocrine gland—hypertension	8.76e-05	0.000953	CbGeAlD
Crizotinib—SRC—adrenal gland—hypertension	8.75e-05	0.000953	CbGeAlD
Crizotinib—ABL1—nephron tubule—hypertension	8.74e-05	0.000951	CbGeAlD
Crizotinib—ABL1—adrenal cortex—hypertension	8.61e-05	0.000936	CbGeAlD
Crizotinib—AURKA—Fluvastatin—Atorvastatin—hypertension	8.6e-05	0.0316	CbGdCrCtD
Crizotinib—MAP3K3—endocrine gland—hypertension	8.54e-05	0.00093	CbGeAlD
Crizotinib—MAP4K5—endocrine gland—hypertension	8.54e-05	0.00093	CbGeAlD
Crizotinib—TEK—endocrine gland—hypertension	8.54e-05	0.00093	CbGeAlD
Crizotinib—RPS6KB1—central nervous system—hypertension	8.5e-05	0.000925	CbGeAlD
Crizotinib—CSF1R—medulla oblongata—hypertension	8.49e-05	0.000924	CbGeAlD
Crizotinib—FGR—central nervous system—hypertension	8.45e-05	0.00092	CbGeAlD
Crizotinib—AXL—central nervous system—hypertension	8.42e-05	0.000916	CbGeAlD
Crizotinib—ABL1—heart—hypertension	8.32e-05	0.000906	CbGeAlD
Crizotinib—ABL1—smooth muscle tissue—hypertension	8.26e-05	0.000898	CbGeAlD
Crizotinib—ABL1—decidua—hypertension	8.1e-05	0.000881	CbGeAlD
Crizotinib—JAK2—central nervous system—hypertension	7.99e-05	0.000869	CbGeAlD
Crizotinib—EPHA2—central nervous system—hypertension	7.89e-05	0.000859	CbGeAlD
Crizotinib—YES1—endocrine gland—hypertension	7.89e-05	0.000859	CbGeAlD
Crizotinib—CSF1R—adrenal gland—hypertension	7.86e-05	0.000855	CbGeAlD
Crizotinib—ABL1—cardiovascular system—hypertension	7.85e-05	0.000855	CbGeAlD
Crizotinib—STK10—endocrine gland—hypertension	7.82e-05	0.000851	CbGeAlD
Crizotinib—TAOK3—endocrine gland—hypertension	7.79e-05	0.000848	CbGeAlD
Crizotinib—MAP4K5—central nervous system—hypertension	7.7e-05	0.000838	CbGeAlD
Crizotinib—MAP3K3—central nervous system—hypertension	7.7e-05	0.000838	CbGeAlD
Crizotinib—TEK—central nervous system—hypertension	7.7e-05	0.000838	CbGeAlD
Crizotinib—ABL1—kidney—hypertension	7.68e-05	0.000836	CbGeAlD
Crizotinib—SRC—endocrine gland—hypertension	7.59e-05	0.000826	CbGeAlD
Crizotinib—ABL1—cortex of kidney—hypertension	7.48e-05	0.000814	CbGeAlD
Crizotinib—EPHB6—central nervous system—hypertension	7.36e-05	0.000801	CbGeAlD
Crizotinib—ABL1—cardiac atrium—hypertension	7.12e-05	0.000775	CbGeAlD
Crizotinib—YES1—central nervous system—hypertension	7.11e-05	0.000774	CbGeAlD
Crizotinib—STK10—central nervous system—hypertension	7.05e-05	0.000767	CbGeAlD
Crizotinib—TAOK3—central nervous system—hypertension	7.02e-05	0.000764	CbGeAlD
Crizotinib—SRC—central nervous system—hypertension	6.84e-05	0.000744	CbGeAlD
Crizotinib—CSF1R—endocrine gland—hypertension	6.82e-05	0.000742	CbGeAlD
Crizotinib—ABL1—medulla oblongata—hypertension	6.71e-05	0.00073	CbGeAlD
Crizotinib—PTK2B—Pindolol—Propranolol—hypertension	6.36e-05	0.0234	CbGdCrCtD
Crizotinib—ABL1—adrenal gland—hypertension	6.21e-05	0.000676	CbGeAlD
Crizotinib—CSF1R—central nervous system—hypertension	6.14e-05	0.000668	CbGeAlD
Crizotinib—CDK7—Terbinafine—Propranolol—hypertension	6.11e-05	0.0225	CbGdCrCtD
Crizotinib—ABCB1—blood vessel—hypertension	5.47e-05	0.000596	CbGeAlD
Crizotinib—ABL1—endocrine gland—hypertension	5.39e-05	0.000586	CbGeAlD
Crizotinib—CYP3A5—nephron tubule—hypertension	5.12e-05	0.000557	CbGeAlD
Crizotinib—ABL1—central nervous system—hypertension	4.85e-05	0.000528	CbGeAlD
Crizotinib—CYP3A5—kidney—hypertension	4.5e-05	0.000489	CbGeAlD
Crizotinib—CYP3A5—cortex of kidney—hypertension	4.38e-05	0.000477	CbGeAlD
Crizotinib—Nausea—Guanabenz—hypertension	3.91e-05	0.000269	CcSEcCtD
Crizotinib—Dysgeusia—Lisinopril—hypertension	3.91e-05	0.000269	CcSEcCtD
Crizotinib—Body temperature increased—Clonidine—hypertension	3.9e-05	0.000269	CcSEcCtD
Crizotinib—Paraesthesia—Furosemide—hypertension	3.9e-05	0.000268	CcSEcCtD
Crizotinib—Dyspepsia—Hydrochlorothiazide—hypertension	3.89e-05	0.000268	CcSEcCtD
Crizotinib—Decreased appetite—Perindopril—hypertension	3.88e-05	0.000267	CcSEcCtD
Crizotinib—Diarrhoea—Fosinopril—hypertension	3.87e-05	0.000267	CcSEcCtD
Crizotinib—Dizziness—Diltiazem—hypertension	3.87e-05	0.000267	CcSEcCtD
Crizotinib—Dizziness—Indapamide—hypertension	3.87e-05	0.000267	CcSEcCtD
Crizotinib—Decreased appetite—Irbesartan—hypertension	3.87e-05	0.000266	CcSEcCtD
Crizotinib—Loss of consciousness—Ramipril—hypertension	3.87e-05	0.000266	CcSEcCtD
Crizotinib—Paraesthesia—Betaxolol—hypertension	3.86e-05	0.000266	CcSEcCtD
Crizotinib—Syncope—Timolol—hypertension	3.86e-05	0.000266	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Perindopril—hypertension	3.86e-05	0.000265	CcSEcCtD
Crizotinib—Diarrhoea—Eplerenone—hypertension	3.85e-05	0.000265	CcSEcCtD
Crizotinib—Fatigue—Perindopril—hypertension	3.85e-05	0.000265	CcSEcCtD
Crizotinib—Vomiting—Propranolol—hypertension	3.84e-05	0.000265	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Irbesartan—hypertension	3.84e-05	0.000265	CcSEcCtD
Crizotinib—Decreased appetite—Hydrochlorothiazide—hypertension	3.84e-05	0.000264	CcSEcCtD
Crizotinib—Fatigue—Irbesartan—hypertension	3.84e-05	0.000264	CcSEcCtD
Crizotinib—Dizziness—Carvedilol—hypertension	3.83e-05	0.000264	CcSEcCtD
Crizotinib—Dyspnoea—Betaxolol—hypertension	3.83e-05	0.000264	CcSEcCtD
Crizotinib—Diarrhoea—Nifedipine—hypertension	3.82e-05	0.000263	CcSEcCtD
Crizotinib—Constipation—Perindopril—hypertension	3.82e-05	0.000263	CcSEcCtD
Crizotinib—Rash—Propranolol—hypertension	3.81e-05	0.000263	CcSEcCtD
Crizotinib—Dermatitis—Propranolol—hypertension	3.81e-05	0.000262	CcSEcCtD
Crizotinib—Body temperature increased—Trandolapril—hypertension	3.81e-05	0.000262	CcSEcCtD
Crizotinib—Diarrhoea—Verapamil—hypertension	3.81e-05	0.000262	CcSEcCtD
Crizotinib—Constipation—Irbesartan—hypertension	3.81e-05	0.000262	CcSEcCtD
Crizotinib—Fatigue—Hydrochlorothiazide—hypertension	3.81e-05	0.000262	CcSEcCtD
Crizotinib—Dizziness—Doxazosin—hypertension	3.79e-05	0.000261	CcSEcCtD
Crizotinib—Body temperature increased—Enalapril—hypertension	3.79e-05	0.000261	CcSEcCtD
Crizotinib—Dyspepsia—Betaxolol—hypertension	3.78e-05	0.000261	CcSEcCtD
Crizotinib—Loss of consciousness—Timolol—hypertension	3.78e-05	0.00026	CcSEcCtD
Crizotinib—Constipation—Hydrochlorothiazide—hypertension	3.77e-05	0.00026	CcSEcCtD
Crizotinib—Decreased appetite—Furosemide—hypertension	3.77e-05	0.00026	CcSEcCtD
Crizotinib—Vision blurred—Lisinopril—hypertension	3.76e-05	0.000259	CcSEcCtD
Crizotinib—Paraesthesia—Losartan—hypertension	3.76e-05	0.000259	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Furosemide—hypertension	3.75e-05	0.000258	CcSEcCtD
Crizotinib—Dizziness—Fosinopril—hypertension	3.74e-05	0.000258	CcSEcCtD
Crizotinib—Fatigue—Furosemide—hypertension	3.74e-05	0.000258	CcSEcCtD
Crizotinib—Body temperature increased—Telmisartan—hypertension	3.74e-05	0.000257	CcSEcCtD
Crizotinib—Decreased appetite—Betaxolol—hypertension	3.74e-05	0.000257	CcSEcCtD
Crizotinib—Dyspnoea—Losartan—hypertension	3.73e-05	0.000257	CcSEcCtD
Crizotinib—Dizziness—Eplerenone—hypertension	3.72e-05	0.000256	CcSEcCtD
Crizotinib—Vomiting—Diltiazem—hypertension	3.72e-05	0.000256	CcSEcCtD
Crizotinib—Vomiting—Indapamide—hypertension	3.72e-05	0.000256	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—hypertension	3.72e-05	0.000256	CcSEcCtD
Crizotinib—Asthenia—Valsartan—hypertension	3.72e-05	0.000256	CcSEcCtD
Crizotinib—Constipation—Furosemide—hypertension	3.71e-05	0.000256	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Betaxolol—hypertension	3.71e-05	0.000256	CcSEcCtD
Crizotinib—Fatigue—Betaxolol—hypertension	3.71e-05	0.000255	CcSEcCtD
Crizotinib—Asthenia—Olmesartan—hypertension	3.7e-05	0.000255	CcSEcCtD
Crizotinib—Dizziness—Nifedipine—hypertension	3.69e-05	0.000254	CcSEcCtD
Crizotinib—Rash—Indapamide—hypertension	3.69e-05	0.000254	CcSEcCtD
Crizotinib—Rash—Diltiazem—hypertension	3.69e-05	0.000254	CcSEcCtD
Crizotinib—Anaemia—Lisinopril—hypertension	3.69e-05	0.000254	CcSEcCtD
Crizotinib—Dermatitis—Indapamide—hypertension	3.69e-05	0.000254	CcSEcCtD
Crizotinib—Dermatitis—Diltiazem—hypertension	3.69e-05	0.000254	CcSEcCtD
Crizotinib—Dyspepsia—Losartan—hypertension	3.69e-05	0.000254	CcSEcCtD
Crizotinib—Vomiting—Carvedilol—hypertension	3.69e-05	0.000254	CcSEcCtD
Crizotinib—Dizziness—Verapamil—hypertension	3.68e-05	0.000253	CcSEcCtD
Crizotinib—Constipation—Betaxolol—hypertension	3.68e-05	0.000253	CcSEcCtD
Crizotinib—Rash—Carvedilol—hypertension	3.65e-05	0.000252	CcSEcCtD
Crizotinib—Dermatitis—Carvedilol—hypertension	3.65e-05	0.000251	CcSEcCtD
Crizotinib—Vomiting—Doxazosin—hypertension	3.64e-05	0.000251	CcSEcCtD
Crizotinib—Decreased appetite—Losartan—hypertension	3.64e-05	0.000251	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	3.64e-05	0.00025	CcSEcCtD
Crizotinib—Body temperature increased—Captopril—hypertension	3.64e-05	0.00025	CcSEcCtD
Crizotinib—Rash—Doxazosin—hypertension	3.61e-05	0.000249	CcSEcCtD
Crizotinib—Fatigue—Losartan—hypertension	3.61e-05	0.000249	CcSEcCtD
Crizotinib—Dermatitis—Doxazosin—hypertension	3.61e-05	0.000249	CcSEcCtD
Crizotinib—Vomiting—Fosinopril—hypertension	3.6e-05	0.000248	CcSEcCtD
Crizotinib—Nausea—Propranolol—hypertension	3.59e-05	0.000247	CcSEcCtD
Crizotinib—Oedema—Ramipril—hypertension	3.59e-05	0.000247	CcSEcCtD
Crizotinib—Constipation—Losartan—hypertension	3.58e-05	0.000247	CcSEcCtD
Crizotinib—Syncope—Lisinopril—hypertension	3.58e-05	0.000246	CcSEcCtD
Crizotinib—Vomiting—Eplerenone—hypertension	3.58e-05	0.000246	CcSEcCtD
Crizotinib—Leukopenia—Lisinopril—hypertension	3.57e-05	0.000246	CcSEcCtD
Crizotinib—Rash—Fosinopril—hypertension	3.57e-05	0.000246	CcSEcCtD
Crizotinib—Dermatitis—Fosinopril—hypertension	3.57e-05	0.000246	CcSEcCtD
Crizotinib—Vomiting—Nifedipine—hypertension	3.55e-05	0.000245	CcSEcCtD
Crizotinib—Rash—Eplerenone—hypertension	3.55e-05	0.000244	CcSEcCtD
Crizotinib—Dermatitis—Eplerenone—hypertension	3.55e-05	0.000244	CcSEcCtD
Crizotinib—Diarrhoea—Valsartan—hypertension	3.54e-05	0.000244	CcSEcCtD
Crizotinib—Asthenia—Clonidine—hypertension	3.54e-05	0.000244	CcSEcCtD
Crizotinib—Vomiting—Verapamil—hypertension	3.54e-05	0.000244	CcSEcCtD
Crizotinib—Shock—Ramipril—hypertension	3.53e-05	0.000243	CcSEcCtD
Crizotinib—Body temperature increased—Perindopril—hypertension	3.53e-05	0.000243	CcSEcCtD
Crizotinib—Diarrhoea—Olmesartan—hypertension	3.53e-05	0.000243	CcSEcCtD
Crizotinib—Rash—Nifedipine—hypertension	3.52e-05	0.000243	CcSEcCtD
Crizotinib—Nervous system disorder—Ramipril—hypertension	3.52e-05	0.000243	CcSEcCtD
Crizotinib—Dermatitis—Nifedipine—hypertension	3.52e-05	0.000242	CcSEcCtD
Crizotinib—Body temperature increased—Irbesartan—hypertension	3.52e-05	0.000242	CcSEcCtD
Crizotinib—Oedema—Timolol—hypertension	3.51e-05	0.000242	CcSEcCtD
Crizotinib—Loss of consciousness—Lisinopril—hypertension	3.51e-05	0.000242	CcSEcCtD
Crizotinib—Rash—Verapamil—hypertension	3.51e-05	0.000242	CcSEcCtD
Crizotinib—Dermatitis—Verapamil—hypertension	3.5e-05	0.000241	CcSEcCtD
Crizotinib—Body temperature increased—Hydrochlorothiazide—hypertension	3.49e-05	0.00024	CcSEcCtD
Crizotinib—Skin disorder—Ramipril—hypertension	3.49e-05	0.00024	CcSEcCtD
Crizotinib—Infection—Timolol—hypertension	3.49e-05	0.00024	CcSEcCtD
Crizotinib—Nausea—Indapamide—hypertension	3.48e-05	0.000239	CcSEcCtD
Crizotinib—Nausea—Diltiazem—hypertension	3.48e-05	0.000239	CcSEcCtD
Crizotinib—Asthenia—Trandolapril—hypertension	3.45e-05	0.000238	CcSEcCtD
Crizotinib—Shock—Timolol—hypertension	3.45e-05	0.000238	CcSEcCtD
Crizotinib—Nervous system disorder—Timolol—hypertension	3.44e-05	0.000237	CcSEcCtD
Crizotinib—Nausea—Carvedilol—hypertension	3.44e-05	0.000237	CcSEcCtD
Crizotinib—Asthenia—Enalapril—hypertension	3.44e-05	0.000237	CcSEcCtD
Crizotinib—Body temperature increased—Furosemide—hypertension	3.43e-05	0.000236	CcSEcCtD
Crizotinib—Dizziness—Valsartan—hypertension	3.42e-05	0.000236	CcSEcCtD
Crizotinib—Skin disorder—Timolol—hypertension	3.41e-05	0.000235	CcSEcCtD
Crizotinib—Dizziness—Olmesartan—hypertension	3.41e-05	0.000235	CcSEcCtD
Crizotinib—Nausea—Doxazosin—hypertension	3.4e-05	0.000234	CcSEcCtD
Crizotinib—Body temperature increased—Betaxolol—hypertension	3.4e-05	0.000234	CcSEcCtD
Crizotinib—Asthenia—Telmisartan—hypertension	3.39e-05	0.000234	CcSEcCtD
Crizotinib—Diarrhoea—Clonidine—hypertension	3.38e-05	0.000233	CcSEcCtD
Crizotinib—CYP3A4—kidney—hypertension	3.38e-05	0.000367	CbGeAlD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	3.37e-05	0.000232	CcSEcCtD
Crizotinib—Nausea—Fosinopril—hypertension	3.36e-05	0.000232	CcSEcCtD
Crizotinib—Nausea—Eplerenone—hypertension	3.34e-05	0.00023	CcSEcCtD
Crizotinib—Nausea—Nifedipine—hypertension	3.32e-05	0.000229	CcSEcCtD
Crizotinib—Body temperature increased—Losartan—hypertension	3.31e-05	0.000228	CcSEcCtD
Crizotinib—Nausea—Verapamil—hypertension	3.3e-05	0.000228	CcSEcCtD
Crizotinib—Asthenia—Captopril—hypertension	3.3e-05	0.000227	CcSEcCtD
Crizotinib—Diarrhoea—Trandolapril—hypertension	3.29e-05	0.000227	CcSEcCtD
Crizotinib—Vomiting—Valsartan—hypertension	3.29e-05	0.000227	CcSEcCtD
Crizotinib—Diarrhoea—Enalapril—hypertension	3.28e-05	0.000226	CcSEcCtD
Crizotinib—Vomiting—Olmesartan—hypertension	3.28e-05	0.000226	CcSEcCtD
Crizotinib—Rash—Valsartan—hypertension	3.27e-05	0.000225	CcSEcCtD
Crizotinib—Dizziness—Clonidine—hypertension	3.26e-05	0.000225	CcSEcCtD
Crizotinib—Dermatitis—Valsartan—hypertension	3.26e-05	0.000225	CcSEcCtD
Crizotinib—Oedema—Lisinopril—hypertension	3.26e-05	0.000224	CcSEcCtD
Crizotinib—Rash—Olmesartan—hypertension	3.25e-05	0.000224	CcSEcCtD
Crizotinib—Dermatitis—Olmesartan—hypertension	3.25e-05	0.000224	CcSEcCtD
Crizotinib—Diarrhoea—Telmisartan—hypertension	3.24e-05	0.000223	CcSEcCtD
Crizotinib—Infection—Lisinopril—hypertension	3.24e-05	0.000223	CcSEcCtD
Crizotinib—Paraesthesia—Ramipril—hypertension	3.22e-05	0.000222	CcSEcCtD
Crizotinib—Shock—Lisinopril—hypertension	3.2e-05	0.000221	CcSEcCtD
Crizotinib—Asthenia—Perindopril—hypertension	3.2e-05	0.000221	CcSEcCtD
Crizotinib—Dyspnoea—Ramipril—hypertension	3.2e-05	0.00022	CcSEcCtD
Crizotinib—Asthenia—Irbesartan—hypertension	3.19e-05	0.00022	CcSEcCtD
Crizotinib—Dizziness—Trandolapril—hypertension	3.18e-05	0.000219	CcSEcCtD
Crizotinib—Dizziness—Enalapril—hypertension	3.17e-05	0.000218	CcSEcCtD
Crizotinib—Asthenia—Hydrochlorothiazide—hypertension	3.17e-05	0.000218	CcSEcCtD
Crizotinib—Skin disorder—Lisinopril—hypertension	3.16e-05	0.000218	CcSEcCtD
Crizotinib—Dyspepsia—Ramipril—hypertension	3.16e-05	0.000218	CcSEcCtD
Crizotinib—CYP3A5—endocrine gland—hypertension	3.15e-05	0.000343	CbGeAlD
Crizotinib—Paraesthesia—Timolol—hypertension	3.15e-05	0.000217	CcSEcCtD
Crizotinib—Diarrhoea—Captopril—hypertension	3.15e-05	0.000217	CcSEcCtD
Crizotinib—Vomiting—Clonidine—hypertension	3.14e-05	0.000216	CcSEcCtD
Crizotinib—Dyspnoea—Timolol—hypertension	3.13e-05	0.000216	CcSEcCtD
Crizotinib—Dizziness—Telmisartan—hypertension	3.13e-05	0.000215	CcSEcCtD
Crizotinib—Decreased appetite—Ramipril—hypertension	3.12e-05	0.000215	CcSEcCtD
Crizotinib—Asthenia—Furosemide—hypertension	3.11e-05	0.000214	CcSEcCtD
Crizotinib—Rash—Clonidine—hypertension	3.11e-05	0.000214	CcSEcCtD
Crizotinib—Dermatitis—Clonidine—hypertension	3.11e-05	0.000214	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Ramipril—hypertension	3.1e-05	0.000214	CcSEcCtD
Crizotinib—Fatigue—Ramipril—hypertension	3.1e-05	0.000213	CcSEcCtD
Crizotinib—Dyspepsia—Timolol—hypertension	3.09e-05	0.000213	CcSEcCtD
Crizotinib—Asthenia—Betaxolol—hypertension	3.08e-05	0.000212	CcSEcCtD
Crizotinib—Nausea—Valsartan—hypertension	3.08e-05	0.000212	CcSEcCtD
Crizotinib—Constipation—Ramipril—hypertension	3.07e-05	0.000211	CcSEcCtD
Crizotinib—Nausea—Olmesartan—hypertension	3.06e-05	0.000211	CcSEcCtD
Crizotinib—Vomiting—Trandolapril—hypertension	3.06e-05	0.000211	CcSEcCtD
Crizotinib—Diarrhoea—Perindopril—hypertension	3.06e-05	0.00021	CcSEcCtD
Crizotinib—Decreased appetite—Timolol—hypertension	3.05e-05	0.00021	CcSEcCtD
Crizotinib—Vomiting—Enalapril—hypertension	3.05e-05	0.00021	CcSEcCtD
Crizotinib—Diarrhoea—Irbesartan—hypertension	3.05e-05	0.00021	CcSEcCtD
Crizotinib—Dizziness—Captopril—hypertension	3.04e-05	0.000209	CcSEcCtD
Crizotinib—Rash—Trandolapril—hypertension	3.04e-05	0.000209	CcSEcCtD
Crizotinib—Dermatitis—Trandolapril—hypertension	3.03e-05	0.000209	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Timolol—hypertension	3.03e-05	0.000209	CcSEcCtD
Crizotinib—Fatigue—Timolol—hypertension	3.03e-05	0.000208	CcSEcCtD
Crizotinib—Rash—Enalapril—hypertension	3.02e-05	0.000208	CcSEcCtD
Crizotinib—Dermatitis—Enalapril—hypertension	3.02e-05	0.000208	CcSEcCtD
Crizotinib—Diarrhoea—Hydrochlorothiazide—hypertension	3.02e-05	0.000208	CcSEcCtD
Crizotinib—Vomiting—Telmisartan—hypertension	3.01e-05	0.000207	CcSEcCtD
Crizotinib—Asthenia—Losartan—hypertension	3.01e-05	0.000207	CcSEcCtD
Crizotinib—Rash—Telmisartan—hypertension	2.98e-05	0.000205	CcSEcCtD
Crizotinib—Dermatitis—Telmisartan—hypertension	2.98e-05	0.000205	CcSEcCtD
Crizotinib—Diarrhoea—Furosemide—hypertension	2.97e-05	0.000205	CcSEcCtD
Crizotinib—Dizziness—Perindopril—hypertension	2.95e-05	0.000203	CcSEcCtD
Crizotinib—Dizziness—Irbesartan—hypertension	2.94e-05	0.000203	CcSEcCtD
Crizotinib—Diarrhoea—Betaxolol—hypertension	2.94e-05	0.000202	CcSEcCtD
Crizotinib—Nausea—Clonidine—hypertension	2.93e-05	0.000202	CcSEcCtD
Crizotinib—Paraesthesia—Lisinopril—hypertension	2.92e-05	0.000201	CcSEcCtD
Crizotinib—Vomiting—Captopril—hypertension	2.92e-05	0.000201	CcSEcCtD
Crizotinib—Dizziness—Hydrochlorothiazide—hypertension	2.92e-05	0.000201	CcSEcCtD
Crizotinib—Dyspnoea—Lisinopril—hypertension	2.9e-05	0.0002	CcSEcCtD
Crizotinib—Rash—Captopril—hypertension	2.9e-05	0.0002	CcSEcCtD
Crizotinib—Dermatitis—Captopril—hypertension	2.9e-05	0.0002	CcSEcCtD
Crizotinib—Dizziness—Furosemide—hypertension	2.87e-05	0.000198	CcSEcCtD
Crizotinib—Dyspepsia—Lisinopril—hypertension	2.87e-05	0.000197	CcSEcCtD
Crizotinib—Diarrhoea—Losartan—hypertension	2.87e-05	0.000197	CcSEcCtD
Crizotinib—Nausea—Trandolapril—hypertension	2.86e-05	0.000197	CcSEcCtD
Crizotinib—Nausea—Enalapril—hypertension	2.85e-05	0.000196	CcSEcCtD
Crizotinib—Dizziness—Betaxolol—hypertension	2.84e-05	0.000196	CcSEcCtD
Crizotinib—Vomiting—Perindopril—hypertension	2.84e-05	0.000196	CcSEcCtD
Crizotinib—Body temperature increased—Ramipril—hypertension	2.84e-05	0.000196	CcSEcCtD
Crizotinib—Decreased appetite—Lisinopril—hypertension	2.83e-05	0.000195	CcSEcCtD
Crizotinib—Vomiting—Irbesartan—hypertension	2.83e-05	0.000195	CcSEcCtD
Crizotinib—Rash—Perindopril—hypertension	2.82e-05	0.000194	CcSEcCtD
Crizotinib—Dermatitis—Perindopril—hypertension	2.81e-05	0.000194	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Lisinopril—hypertension	2.81e-05	0.000194	CcSEcCtD
Crizotinib—Nausea—Telmisartan—hypertension	2.81e-05	0.000193	CcSEcCtD
Crizotinib—Fatigue—Lisinopril—hypertension	2.81e-05	0.000193	CcSEcCtD
Crizotinib—Vomiting—Hydrochlorothiazide—hypertension	2.81e-05	0.000193	CcSEcCtD
Crizotinib—Rash—Irbesartan—hypertension	2.81e-05	0.000193	CcSEcCtD
Crizotinib—Dermatitis—Irbesartan—hypertension	2.8e-05	0.000193	CcSEcCtD
Crizotinib—Constipation—Lisinopril—hypertension	2.79e-05	0.000192	CcSEcCtD
Crizotinib—Rash—Hydrochlorothiazide—hypertension	2.78e-05	0.000192	CcSEcCtD
Crizotinib—Dermatitis—Hydrochlorothiazide—hypertension	2.78e-05	0.000191	CcSEcCtD
Crizotinib—Body temperature increased—Timolol—hypertension	2.78e-05	0.000191	CcSEcCtD
Crizotinib—Dizziness—Losartan—hypertension	2.77e-05	0.000191	CcSEcCtD
Crizotinib—Vomiting—Furosemide—hypertension	2.76e-05	0.00019	CcSEcCtD
Crizotinib—Rash—Furosemide—hypertension	2.74e-05	0.000188	CcSEcCtD
Crizotinib—Dermatitis—Furosemide—hypertension	2.73e-05	0.000188	CcSEcCtD
Crizotinib—Vomiting—Betaxolol—hypertension	2.73e-05	0.000188	CcSEcCtD
Crizotinib—Nausea—Captopril—hypertension	2.73e-05	0.000188	CcSEcCtD
Crizotinib—ABCB1—nephron tubule—hypertension	2.72e-05	0.000296	CbGeAlD
Crizotinib—Rash—Betaxolol—hypertension	2.71e-05	0.000187	CcSEcCtD
Crizotinib—Dermatitis—Betaxolol—hypertension	2.71e-05	0.000186	CcSEcCtD
Crizotinib—ABCB1—adrenal cortex—hypertension	2.68e-05	0.000291	CbGeAlD
Crizotinib—Vomiting—Losartan—hypertension	2.66e-05	0.000183	CcSEcCtD
Crizotinib—Nausea—Perindopril—hypertension	2.65e-05	0.000183	CcSEcCtD
Crizotinib—Nausea—Irbesartan—hypertension	2.64e-05	0.000182	CcSEcCtD
Crizotinib—Rash—Losartan—hypertension	2.64e-05	0.000182	CcSEcCtD
Crizotinib—Dermatitis—Losartan—hypertension	2.64e-05	0.000182	CcSEcCtD
Crizotinib—Nausea—Hydrochlorothiazide—hypertension	2.62e-05	0.000181	CcSEcCtD
Crizotinib—ABCB1—heart—hypertension	2.59e-05	0.000282	CbGeAlD
Crizotinib—Nausea—Furosemide—hypertension	2.58e-05	0.000178	CcSEcCtD
Crizotinib—Asthenia—Ramipril—hypertension	2.58e-05	0.000177	CcSEcCtD
Crizotinib—Body temperature increased—Lisinopril—hypertension	2.57e-05	0.000177	CcSEcCtD
Crizotinib—Nausea—Betaxolol—hypertension	2.55e-05	0.000176	CcSEcCtD
Crizotinib—Asthenia—Timolol—hypertension	2.52e-05	0.000173	CcSEcCtD
Crizotinib—ABCB1—decidua—hypertension	2.52e-05	0.000274	CbGeAlD
Crizotinib—Nausea—Losartan—hypertension	2.49e-05	0.000171	CcSEcCtD
Crizotinib—Diarrhoea—Ramipril—hypertension	2.46e-05	0.000169	CcSEcCtD
Crizotinib—ABCB1—cardiovascular system—hypertension	2.44e-05	0.000266	CbGeAlD
Crizotinib—Diarrhoea—Timolol—hypertension	2.4e-05	0.000165	CcSEcCtD
Crizotinib—ABCB1—kidney—hypertension	2.39e-05	0.00026	CbGeAlD
Crizotinib—Dizziness—Ramipril—hypertension	2.37e-05	0.000164	CcSEcCtD
Crizotinib—CYP3A4—endocrine gland—hypertension	2.37e-05	0.000258	CbGeAlD
Crizotinib—Asthenia—Lisinopril—hypertension	2.34e-05	0.000161	CcSEcCtD
Crizotinib—ABCB1—cortex of kidney—hypertension	2.33e-05	0.000253	CbGeAlD
Crizotinib—Dizziness—Timolol—hypertension	2.32e-05	0.00016	CcSEcCtD
Crizotinib—Vomiting—Ramipril—hypertension	2.28e-05	0.000157	CcSEcCtD
Crizotinib—Rash—Ramipril—hypertension	2.26e-05	0.000156	CcSEcCtD
Crizotinib—Dermatitis—Ramipril—hypertension	2.26e-05	0.000156	CcSEcCtD
Crizotinib—Vomiting—Timolol—hypertension	2.23e-05	0.000154	CcSEcCtD
Crizotinib—Diarrhoea—Lisinopril—hypertension	2.23e-05	0.000153	CcSEcCtD
Crizotinib—Rash—Timolol—hypertension	2.21e-05	0.000152	CcSEcCtD
Crizotinib—Dermatitis—Timolol—hypertension	2.21e-05	0.000152	CcSEcCtD
Crizotinib—Dizziness—Lisinopril—hypertension	2.15e-05	0.000148	CcSEcCtD
Crizotinib—Nausea—Ramipril—hypertension	2.13e-05	0.000147	CcSEcCtD
Crizotinib—CYP3A4—central nervous system—hypertension	2.13e-05	0.000232	CbGeAlD
Crizotinib—ABCB1—medulla oblongata—hypertension	2.09e-05	0.000227	CbGeAlD
Crizotinib—Nausea—Timolol—hypertension	2.09e-05	0.000144	CcSEcCtD
Crizotinib—Vomiting—Lisinopril—hypertension	2.07e-05	0.000143	CcSEcCtD
Crizotinib—Rash—Lisinopril—hypertension	2.05e-05	0.000141	CcSEcCtD
Crizotinib—Dermatitis—Lisinopril—hypertension	2.05e-05	0.000141	CcSEcCtD
Crizotinib—Nausea—Lisinopril—hypertension	1.93e-05	0.000133	CcSEcCtD
Crizotinib—ABCB1—adrenal gland—hypertension	1.93e-05	0.00021	CbGeAlD
Crizotinib—ABCB1—endocrine gland—hypertension	1.68e-05	0.000182	CbGeAlD
Crizotinib—ABCB1—central nervous system—hypertension	1.51e-05	0.000164	CbGeAlD
Crizotinib—CYP3A5—Metabolism—CAV1—hypertension	2.88e-07	1.76e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TGFB1—hypertension	2.88e-07	1.76e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GNB3—hypertension	2.88e-07	1.75e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PPARGC1A—hypertension	2.88e-07	1.75e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—APOA1—hypertension	2.88e-07	1.75e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—CDKN1A—hypertension	2.88e-07	1.75e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—PTEN—hypertension	2.87e-07	1.75e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—HMOX1—hypertension	2.86e-07	1.75e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NOTCH1—hypertension	2.86e-07	1.75e-06	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—AKT1—hypertension	2.86e-07	1.75e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—EP300—hypertension	2.85e-07	1.74e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TP53—hypertension	2.85e-07	1.74e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—VEGFA—hypertension	2.85e-07	1.74e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—MYC—hypertension	2.85e-07	1.74e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CXCL8—hypertension	2.84e-07	1.73e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TGFB1—hypertension	2.84e-07	1.73e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—MYC—hypertension	2.84e-07	1.73e-06	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—AKT1—hypertension	2.84e-07	1.73e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—TGFB1—hypertension	2.83e-07	1.73e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CAT—hypertension	2.83e-07	1.72e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—EGFR—hypertension	2.83e-07	1.72e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—RELA—hypertension	2.82e-07	1.72e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—IL6—hypertension	2.82e-07	1.72e-06	CbGpPWpGaD
Crizotinib—TYK2—Immune System—AKT1—hypertension	2.81e-07	1.71e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—MAPK8—hypertension	2.81e-07	1.71e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GNAS—hypertension	2.8e-07	1.71e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—EGFR—hypertension	2.79e-07	1.7e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—EGFR—hypertension	2.78e-07	1.69e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—SRC—hypertension	2.77e-07	1.69e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MTOR—hypertension	2.77e-07	1.69e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—IL6—hypertension	2.77e-07	1.69e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TP53—hypertension	2.77e-07	1.69e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—SERPINE1—hypertension	2.75e-07	1.68e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—APOB—hypertension	2.74e-07	1.67e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—EP300—hypertension	2.74e-07	1.67e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—IL6—hypertension	2.73e-07	1.66e-06	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—AKT1—hypertension	2.73e-07	1.66e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ALDH2—hypertension	2.71e-07	1.65e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—MYC—hypertension	2.7e-07	1.65e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TGFB1—hypertension	2.7e-07	1.64e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GSTM1—hypertension	2.67e-07	1.63e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—POMC—hypertension	2.67e-07	1.63e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—FGF2—hypertension	2.66e-07	1.62e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CXCL8—hypertension	2.66e-07	1.62e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—CDKN1A—hypertension	2.65e-07	1.62e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—RHOA—hypertension	2.65e-07	1.62e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—INS—hypertension	2.65e-07	1.62e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—PTEN—hypertension	2.65e-07	1.61e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—HBA1—hypertension	2.65e-07	1.61e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—EGFR—hypertension	2.64e-07	1.61e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—EGFR—hypertension	2.63e-07	1.61e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CYP11A1—hypertension	2.63e-07	1.6e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—NOS3—hypertension	2.63e-07	1.6e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PIK3R1—hypertension	2.63e-07	1.6e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—MYC—hypertension	2.62e-07	1.6e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—LPL—hypertension	2.62e-07	1.6e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TGFB1—hypertension	2.62e-07	1.59e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—IL6—hypertension	2.61e-07	1.59e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CCL2—hypertension	2.61e-07	1.59e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—AKT1—hypertension	2.6e-07	1.58e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GSTT1—hypertension	2.58e-07	1.57e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—SLC9A1—hypertension	2.58e-07	1.57e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—MMP9—hypertension	2.57e-07	1.57e-06	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—AKT1—hypertension	2.57e-07	1.57e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—EGFR—hypertension	2.57e-07	1.56e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ADCY5—hypertension	2.57e-07	1.56e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IGF1—hypertension	2.57e-07	1.56e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—AKT2—hypertension	2.56e-07	1.56e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CDKN1A—hypertension	2.56e-07	1.56e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GPX1—hypertension	2.56e-07	1.56e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—PTEN—hypertension	2.56e-07	1.56e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—AKT1—hypertension	2.55e-07	1.56e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CETP—hypertension	2.55e-07	1.56e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GCLC—hypertension	2.55e-07	1.56e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PPARG—hypertension	2.54e-07	1.54e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—IL6—hypertension	2.53e-07	1.54e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PRKCA—hypertension	2.53e-07	1.54e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CYP1A1—hypertension	2.53e-07	1.54e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—IL6—hypertension	2.53e-07	1.54e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—EP300—hypertension	2.53e-07	1.54e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—AKT1—hypertension	2.52e-07	1.53e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—MAPK8—hypertension	2.5e-07	1.52e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—POMC—hypertension	2.5e-07	1.52e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CD36—hypertension	2.49e-07	1.52e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—MYC—hypertension	2.49e-07	1.52e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—INS—hypertension	2.49e-07	1.52e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—TGFB1—hypertension	2.48e-07	1.51e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—RELA—hypertension	2.47e-07	1.51e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL6—hypertension	2.47e-07	1.51e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL6—hypertension	2.46e-07	1.5e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CYP17A1—hypertension	2.44e-07	1.49e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—EP300—hypertension	2.44e-07	1.49e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—SERPINE1—hypertension	2.44e-07	1.48e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—EGFR—hypertension	2.43e-07	1.48e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MTOR—hypertension	2.42e-07	1.48e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ENO1—hypertension	2.42e-07	1.47e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PTGS1—hypertension	2.42e-07	1.47e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—AKT1—hypertension	2.41e-07	1.47e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MMP9—hypertension	2.41e-07	1.47e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CDKN1A—hypertension	2.4e-07	1.46e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—PTEN—hypertension	2.39e-07	1.46e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TP53—hypertension	2.37e-07	1.45e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—SRC—hypertension	2.37e-07	1.44e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—MTHFR—hypertension	2.36e-07	1.44e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—FGF2—hypertension	2.36e-07	1.44e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—RHOA—hypertension	2.35e-07	1.43e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MAPK8—hypertension	2.34e-07	1.43e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TP53—hypertension	2.34e-07	1.43e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—AKT1—hypertension	2.34e-07	1.42e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—AKT1—hypertension	2.33e-07	1.42e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—EGFR—hypertension	2.33e-07	1.42e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CXCL8—hypertension	2.33e-07	1.42e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CTGF—hypertension	2.33e-07	1.42e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PIK3R1—hypertension	2.33e-07	1.42e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NOS3—hypertension	2.33e-07	1.42e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PPARA—hypertension	2.31e-07	1.41e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL6—hypertension	2.31e-07	1.41e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—VEGFA—hypertension	2.31e-07	1.41e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—HMGCR—hypertension	2.31e-07	1.41e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GOT2—hypertension	2.31e-07	1.41e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—EP300—hypertension	2.28e-07	1.39e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ALB—hypertension	2.28e-07	1.39e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—AKT1—hypertension	2.28e-07	1.39e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—AKT1—hypertension	2.27e-07	1.38e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ADRA2A—hypertension	2.26e-07	1.38e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—AGT—hypertension	2.24e-07	1.37e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TP53—hypertension	2.22e-07	1.35e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—SRC—hypertension	2.22e-07	1.35e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CALM1—hypertension	2.2e-07	1.34e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—MYC—hypertension	2.2e-07	1.34e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—APOE—hypertension	2.2e-07	1.34e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—TGFB1—hypertension	2.2e-07	1.34e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—RELA—hypertension	2.19e-07	1.33e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PIK3R1—hypertension	2.18e-07	1.33e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—NOS3—hypertension	2.18e-07	1.33e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CAV1—hypertension	2.18e-07	1.33e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—IL6—hypertension	2.17e-07	1.32e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—APOA1—hypertension	2.17e-07	1.32e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—VEGFA—hypertension	2.16e-07	1.32e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TP53—hypertension	2.15e-07	1.31e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—EGFR—hypertension	2.15e-07	1.31e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MTOR—hypertension	2.15e-07	1.31e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—IL6—hypertension	2.14e-07	1.31e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—IL6—hypertension	2.13e-07	1.3e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—AKT1—hypertension	2.13e-07	1.3e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—MYC—hypertension	2.12e-07	1.29e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TGFB1—hypertension	2.12e-07	1.29e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—TH—hypertension	2.11e-07	1.29e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MMP9—hypertension	2.11e-07	1.28e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CALM2—hypertension	2.11e-07	1.28e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CDKN1A—hypertension	2.1e-07	1.28e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PTEN—hypertension	2.1e-07	1.28e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—EGFR—hypertension	2.08e-07	1.27e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CXCL8—hypertension	2.06e-07	1.26e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GCG—hypertension	2.06e-07	1.25e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—SLC2A4—hypertension	2.06e-07	1.25e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MAPK8—hypertension	2.05e-07	1.25e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—IL6—hypertension	2.03e-07	1.24e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL6—hypertension	2.02e-07	1.23e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—AKT1—hypertension	2e-07	1.22e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—EP300—hypertension	2e-07	1.22e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PTGS2—hypertension	1.99e-07	1.22e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GOT1—hypertension	1.99e-07	1.21e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MYC—hypertension	1.99e-07	1.21e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TGFB1—hypertension	1.98e-07	1.21e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—AKT1—hypertension	1.98e-07	1.2e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—IL6—hypertension	1.97e-07	1.2e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—AKT1—hypertension	1.97e-07	1.2e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—EGFR—hypertension	1.94e-07	1.18e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—SRC—hypertension	1.94e-07	1.18e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—STK11—hypertension	1.93e-07	1.18e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CYP19A1—hypertension	1.93e-07	1.18e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PPARG—hypertension	1.91e-07	1.17e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—VEGFA—hypertension	1.89e-07	1.15e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—POMC—hypertension	1.89e-07	1.15e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—INS—hypertension	1.88e-07	1.14e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—AKT1—hypertension	1.87e-07	1.14e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—IL6—hypertension	1.87e-07	1.14e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—AKT1—hypertension	1.87e-07	1.14e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MMP9—hypertension	1.87e-07	1.14e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CDKN1A—hypertension	1.86e-07	1.13e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PTEN—hypertension	1.85e-07	1.13e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—AKT1—hypertension	1.82e-07	1.11e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MAPK8—hypertension	1.81e-07	1.11e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—COMT—hypertension	1.8e-07	1.1e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL6—hypertension	1.79e-07	1.09e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GNB3—hypertension	1.77e-07	1.08e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PPARGC1A—hypertension	1.77e-07	1.08e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—EP300—hypertension	1.77e-07	1.08e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—HMOX1—hypertension	1.77e-07	1.08e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TP53—hypertension	1.74e-07	1.06e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CAT—hypertension	1.74e-07	1.06e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MYC—hypertension	1.74e-07	1.06e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PTEN—hypertension	1.74e-07	1.06e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TGFB1—hypertension	1.74e-07	1.06e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GNAS—hypertension	1.73e-07	1.05e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—AKT1—hypertension	1.72e-07	1.05e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ALB—hypertension	1.72e-07	1.05e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—EGFR—hypertension	1.7e-07	1.04e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—APOB—hypertension	1.69e-07	1.03e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—VEGFA—hypertension	1.68e-07	1.02e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—EP300—hypertension	1.66e-07	1.01e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—IL6—hypertension	1.65e-07	1.01e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—AKT1—hypertension	1.65e-07	1.01e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PIK3R1—hypertension	1.65e-07	1e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—NOS3—hypertension	1.65e-07	1e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GSTM1—hypertension	1.64e-07	1e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TP53—hypertension	1.63e-07	9.95e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—LPL—hypertension	1.61e-07	9.84e-07	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—IL6—hypertension	1.6e-07	9.73e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ADCY5—hypertension	1.58e-07	9.63e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GPX1—hypertension	1.58e-07	9.6e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CYP1A1—hypertension	1.56e-07	9.5e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PRKCA—hypertension	1.56e-07	9.5e-07	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MYC—hypertension	1.54e-07	9.39e-07	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TGFB1—hypertension	1.54e-07	9.37e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CD36—hypertension	1.53e-07	9.35e-07	CbGpPWpGaD
Crizotinib—SRC—Disease—AKT1—hypertension	1.53e-07	9.3e-07	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—EGFR—hypertension	1.51e-07	9.19e-07	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PTGS2—hypertension	1.5e-07	9.17e-07	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IL6—hypertension	1.49e-07	9.11e-07	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—AKT1—hypertension	1.47e-07	8.98e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—MTHFR—hypertension	1.45e-07	8.86e-07	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TP53—hypertension	1.43e-07	8.71e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PPARA—hypertension	1.43e-07	8.69e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—AGT—hypertension	1.38e-07	8.42e-07	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—AKT1—hypertension	1.38e-07	8.4e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CALM1—hypertension	1.36e-07	8.28e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—APOE—hypertension	1.35e-07	8.25e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CAV1—hypertension	1.34e-07	8.17e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—APOA1—hypertension	1.34e-07	8.15e-07	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PTEN—hypertension	1.31e-07	8e-07	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IL6—hypertension	1.31e-07	7.98e-07	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TP53—hypertension	1.27e-07	7.71e-07	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—EP300—hypertension	1.25e-07	7.63e-07	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—AKT1—hypertension	1.21e-07	7.36e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PPARG—hypertension	1.18e-07	7.18e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—POMC—hypertension	1.16e-07	7.08e-07	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IL6—hypertension	1.16e-07	7.06e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—INS—hypertension	1.16e-07	7.04e-07	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—AKT1—hypertension	1.07e-07	6.51e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ALB—hypertension	1.06e-07	6.46e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PIK3R1—hypertension	1.01e-07	6.18e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—NOS3—hypertension	1.01e-07	6.18e-07	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—AKT1—hypertension	1e-07	6.11e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PTGS2—hypertension	9.27e-08	5.65e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PTEN—hypertension	8.09e-08	4.93e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—EP300—hypertension	7.71e-08	4.7e-07	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—AKT1—hypertension	7.56e-08	4.61e-07	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—AKT1—hypertension	4.66e-08	2.84e-07	CbGpPWpGaD
